Deprecated: Function split() is deprecated in /hermes/bosnacweb05/bosnacweb05ae/b1401/ipw.angiobio/public_html/new/new/classes/box/categorybox.php on line 39
Browse NEW products!
Browse antibodies
anti-human LYVE-1
Overview
Catalog #11-032
Unit Size100 ug
ApplicationsW, E, IHC
Hostrabbit
Price$300.00
Description:
LYVE-1 has been identified as a major receptor for HA (extracellular matrix glycosaminoglycan hyaluronan) on the lymph vessel wall. The deduced amino acid sequence of LYVE-1 predicts a 322-residue type I integral membrane polypeptide 41% similar to the CD44 HA receptor with a 212-residue extracellular domain containing a single Link module the prototypic HA binding domain of the Link protein superfamily. LYVE-1 is the first lymph-specific HA receptor to be characterized. Later, LYVE-1 was reported to express in liver sinusoid blood vessels. However, in most tissues, LVYE-1 is a specific marker for lymph vessels.
 
Host Species: Rabbit
Buffer: PBS
Formulation: Rabbit IgG
 
Stability: The antibody should be stored at –20°C. 
 
Cross-Reactivity: The antibody has not been showed to cross-react with LYVE-1 from mouse or other species.
 
Specificity: The antibody will detect human LYVE-1 on the surface of lymphatic endothelial cells by immunohistochemistry. The antibody detects a 70 KD LYVE-1 band in Western blotting.
 
Immunohistochemistry: Use at 1:100 dilution. A boiling step is recommended when staining paraffin embedded sections.
 
Western blotting: Use at 1:200 dilution with the appropriate secondary reagents.

Optimal dilutions should be determined by each laboratory for each application.
 
Usage: This antibody is offered for research use only. Not for human use!
Image
Publication (0)
Related Products
Name Catalog # Reactivity Application Publication Image Price
anti-human podoplanin NZ-1 11-009 human W, IHC(F/P) IF, FC -- (1)$280.00
Home | Products | Service | About Us | Contact Us | Order | Distributor | In The News | Publications |
© Copyright 2011. AngioBio.com. All Rights Reserved. Privacy Policy | Terms & Conditions | Site by